Pediatrix Medical Group, Inc. MD

Set alert

Price alert · MD

All alert types
30.71 USD +0.89 +2.98%

At close

30.71 0.00 0.00%

Pre-market · Nov 3, 4:00 AM ET

Bid
30.56 × 1
Ask
30.73 × 1
29.61 Day range 31.07
17.23 52-week range 31.07
YTD
+43.57%
1 year
+45.68%
Open
30.11
Prev close
29.82
Mkt cap
2.40B
Vol
1.17M
Avg vol
770.37K
EPS
1.83
P/E
16.78
Div yield
0.00%
More statistics
Low
29.61
High
31.07
Forward P/E
12.42
Beta
0.61
Short ratio
5.77
Inst. own
111.37%
Dividend
0.00
Ex-div date
Earnings
Feb 18, 2027
50-d avg
26.93
200-d avg
23.87
1y target
29.17

1D chart

Chart tools
Interval

Signals (69)
NameTimeAgo
SMA: Bearish3:55 PM15 hours ago
SMA: Bearish3:50 PM15 hours ago
SMA: Bullish3:49 PM15 hours ago
SMA: Bearish3:48 PM15 hours ago
MACD: Sell Signal3:45 PM15 hours ago
RSI: Overbought3:35 PM15 hours ago
RSI: Overbought3:32 PM15 hours ago
SMA: Bullish3:23 PM15 hours ago
SMA: Bullish3:23 PM15 hours ago
MACD: Buy Signal3:22 PM15 hours ago
SMA: Bearish3:07 PM16 hours ago
MACD: Sell Signal3:07 PM16 hours ago
MACD: Buy Signal3:04 PM16 hours ago
SMA: Bullish3:03 PM16 hours ago
SMA: Bearish3:01 PM16 hours ago
MACD: Sell Signal2:59 PM16 hours ago
SMA: Bullish2:56 PM16 hours ago
SMA: Bearish2:52 PM16 hours ago
SMA: Bearish2:52 PM16 hours ago
RSI: Overbought2:51 PM16 hours ago

Newest 20 of 69.

Financial health

Altman Z-Score

2.46 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 3

Valuation

P/E 11.0×
FY 2016: 19.2×FY 2017: 15.6×FY 2018: 11.2×FY 2019: -1.6×FY 2020: -2.6×FY 2021: 17.9×FY 2022: 18.6×FY 2023: -12.7×FY 2024: -11.0×FY 2025: 11.0×
FY 2016 5y median 11.0× FY 2025
P/S 1.0×
FY 2016: 1.9×FY 2017: 1.4×FY 2018: 0.8×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 1.2×FY 2022: 0.6×FY 2023: 0.4×FY 2024: 0.5×FY 2025: 1.0×
FY 2016 5y median 0.6× FY 2025
P/B 2.1×
FY 2016: 2.2×FY 2017: 1.6×FY 2018: 1.0×FY 2019: 1.6×FY 2020: 2.8×FY 2021: 2.6×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 1.4×FY 2025: 2.1×
FY 2016 5y median 1.4× FY 2025
P/FCF 7.2×
FY 2016: 15.2×FY 2017: 10.7×FY 2018: 12.5×FY 2019: 6.9×FY 2020: 11.9×FY 2021: 52.9×FY 2022: 9.0×FY 2023: 7.4×FY 2024: 5.9×FY 2025: 7.2×
FY 2016 5y median 7.4× FY 2025
EV/EBITDA 7.7×
FY 2016: 11.8×FY 2017: 11.5×FY 2018: 10.6×FY 2019: 19.8×FY 2020: 19.0×FY 2021: 12.8×FY 2022: 12.4×FY 2023: 46.6×FY 2024: -53.8×FY 2025: 7.7×
FY 2016 5y median 12.4× FY 2025
EV/Sales 1.1×
FY 2016: 2.5×FY 2017: 1.9×FY 2018: 1.4×FY 2019: 2.3×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
FCF Yield 13.9%
FY 2016: 6.6%FY 2017: 9.4%FY 2018: 8.0%FY 2019: 14.5%FY 2020: 8.4%FY 2021: 1.9%FY 2022: 11.1%FY 2023: 13.6%FY 2024: 16.9%FY 2025: 13.9%
FY 2016 5y median 13.6% FY 2025

Profitability

Gross Margin 24.7%
FY 2016: 32.5%FY 2017: 28.9%FY 2018: 27.1%FY 2019: 28.3%FY 2020: 25.9%FY 2021: 26.9%FY 2022: 23.7%FY 2023: 21.1%FY 2024: 22.6%FY 2025: 24.7%
FY 2016 5y median 23.7% FY 2025
Operating Margin 12.1%
FY 2016: 18.0%FY 2017: 13.9%FY 2018: 12.2%FY 2019: 9.7%FY 2020: 5.7%FY 2021: 10.6%FY 2022: 8.8%FY 2023: 0.4%FY 2024: -3.4%FY 2025: 12.1%
FY 2016 5y median 8.8% FY 2025
Net Margin 8.6%
FY 2016: 10.2%FY 2017: 9.3%FY 2018: 7.4%FY 2019: -84.2%FY 2020: -45.9%FY 2021: 6.9%FY 2022: 3.4%FY 2023: -3.0%FY 2024: -4.9%FY 2025: 8.6%
FY 2016 5y median 3.4% FY 2025
ROE 19.1%
FY 2016: 11.8%FY 2017: 10.4%FY 2018: 8.7%FY 2019: -99.9%FY 2020: -106.6%FY 2021: 14.6%FY 2022: 7.4%FY 2023: -7.1%FY 2024: -13.0%FY 2025: 19.1%
FY 2016 5y median 7.4% FY 2025
ROIC 9.7%
FY 2016: 7.3%FY 2017: 6.9%FY 2018: 5.9%FY 2019: 3.4%FY 2020: -4.5%FY 2021: 7.0%FY 2022: 6.8%FY 2023: 0.4%FY 2024: -3.8%FY 2025: 9.7%
FY 2016 5y median 6.8% FY 2025
ROA 7.4%
FY 2016: 6.1%FY 2017: 5.5%FY 2018: 4.5%FY 2019: -36.1%FY 2020: -23.8%FY 2021: 4.8%FY 2022: 2.8%FY 2023: -2.7%FY 2024: -4.6%FY 2025: 7.4%
FY 2016 5y median 2.8% FY 2025

Growth (YoY)

Revenue -4.9%
FY 2016: 14.5%FY 2017: 8.6%FY 2018: 5.5%FY 2019: -51.2%FY 2020: -2.6%FY 2021: 10.2%FY 2022: 3.2%FY 2023: 1.1%FY 2024: 0.9%FY 2025: -4.9%
FY 2016 FY 2025
Operating Income 436.3%
FY 2016: 2.5%FY 2017: -16.0%FY 2018: -7.1%FY 2019: -61.5%FY 2020: -42.9%FY 2021: 106.8%FY 2022: -14.9%FY 2023: -95.8%FY 2024: -1038.6%FY 2025: 436.3%
FY 2016 FY 2025
EPS (diluted) 263.0%
FY 2016: -3.1%FY 2017: -1.4%FY 2018: -14.3%FY 2019: -712.3%FY 2020: 46.8%FY 2021: 115.9%FY 2022: -48.0%FY 2023: -192.4%FY 2024: -63.0%FY 2025: 263.0%
FY 2016 FY 2025
Free Cash Flow 36.9%
FY 2016: 18.4%FY 2017: 14.2%FY 2018: -47.8%FY 2019: 40.4%FY 2020: -48.0%FY 2021: -74.7%FY 2022: 208.5%FY 2023: -24.2%FY 2024: 77.5%FY 2025: 36.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.7×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.8×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 1.2×FY 2020: 2.4×FY 2021: 1.2×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: 2.5×FY 2017: 3.0×FY 2018: 4.1×FY 2019: 8.3×FY 2020: 4.7×FY 2021: 2.9×FY 2022: 4.5×FY 2023: 21.0×FY 2024: -15.2×FY 2025: 1.0×
FY 2016 5y median 2.9× FY 2025
Interest Coverage 6.4×
FY 2016: 9.1×FY 2017: 6.4×FY 2018: 4.8×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 3.0×FY 2022: 4.4×FY 2023: 0.2×FY 2024: -1.7×FY 2025: 6.4×
FY 2016 5y median 3.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31